Core Viewpoint - Natural Gas Services (NGS) shares have increased by 6.8% recently, with analysts suggesting a potential upside of 41.7% based on a mean price target of $36.25 [1][11]. Price Targets - The average price target for NGS ranges from a low of $32.00 to a high of $45.00, with a standard deviation of $5.97, indicating variability among analysts [2]. - The lowest estimate suggests a 25.1% increase, while the highest points to a 75.9% upside [2]. Analyst Sentiment - There is strong agreement among analysts regarding NGS's ability to report better earnings, which supports the expectation of an upside [4][11]. - Over the past 30 days, the Zacks Consensus Estimate for the current year has risen by 5.7%, with no negative revisions [12]. Zacks Rank - NGS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Conclusion on Price Movement - While consensus price targets may not be entirely reliable, the direction indicated by these targets appears to be a useful guide for potential price movement [14].

Core Viewpoint - U.S. Physical Therapy (USPH) has shown a significant price increase of 17.5% over the past four weeks, with analysts projecting a mean price target of $109.67, indicating a potential upside of 26.5% from the current price of $86.71 [1] Price Targets and Analyst Consensus - The average price target from six analysts ranges from a low of $98.00 to a high of $124.00, with a standard deviation of $8.91, suggesting a relatively tight clustering of estimates [2] - The lowest estimate indicates a 13% increase, while the highest suggests a 43% upside, highlighting the variability in analyst predictions [2][9] - Analysts' price targets are often viewed with skepticism due to historical inaccuracies in predicting actual stock movements [7][10] Earnings Estimates and Market Sentiment - Analysts are optimistic about USPH's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which have shown a strong correlation with stock price movements [11] - Over the last 30 days, two earnings estimates for USPH have been revised upward, leading to a 4.6% increase in the Zacks Consensus Estimate [12] - USPH holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, further supporting its potential upside [13] Conclusion on Price Movement - While the consensus price target may not be a reliable predictor of the magnitude of USPH's gains, the direction indicated by these targets appears to be a useful guide for potential price movement [14]

Group 1 - Avadel (AVDL) shares have increased by 32.7% over the past four weeks, closing at $12.75, with a mean price target of $17.5 indicating a potential upside of 37.3% [1] - The mean estimate consists of eight short-term price targets with a standard deviation of $3.38, where the lowest estimate is $12.00 (5.9% decline) and the highest is $22.00 (72.6% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 15.5% over the past month [11][12] Group 2 - AVDL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - The clustering of price targets with a low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] - While price targets can be misleading, the direction they imply may serve as a useful guide for potential price movements [10][14]

Core Viewpoint - Payoneer Global Inc. (PAYO) has seen a 2.5% increase in share price over the past four weeks, closing at $6.64, with analysts suggesting a potential upside of 44% based on a mean price target of $9.56 [1][11]. Price Targets and Analyst Estimates - The mean estimate for PAYO comprises nine short-term price targets with a standard deviation of $1.67, indicating variability among analysts [2]. - The lowest price target is $7.00, suggesting a 5.4% increase, while the highest target is $12.00, indicating an 80.7% potential increase [2]. - A low standard deviation signifies strong agreement among analysts regarding the stock's price movement [9]. Earnings Estimates and Analyst Sentiment - Analysts have shown strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases [11]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.3%, with two estimates moving higher and no negative revisions [12]. - PAYO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Caution on Price Targets - While price targets are a common metric for investors, relying solely on them may not be prudent due to historical inaccuracies in predicting stock movements [3][7]. - Analysts often set optimistic price targets influenced by business relationships, which can lead to inflated estimates [8][10].

Group 1 - Superior Group (SGC) shares have increased by 2.7% over the past four weeks, closing at $11.42, with a mean price target of $17.8 indicating a potential upside of 55.9% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $4.15, where the lowest estimate is $14.00 (22.6% increase) and the highest is $24.00 (110.2% increase) [2] - Analysts show a strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as the Zacks Consensus Estimate has increased by 10.7% [11][12] Group 2 - The consensus price target is often viewed as a key metric, but relying solely on it for investment decisions may not be prudent due to the questionable ability of analysts in setting these targets [3][7] - Analysts may set overly optimistic price targets influenced by business relationships, which can lead to inflated expectations [8] - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding the stock's price movement direction, serving as a starting point for further research [9] Group 3 - SGC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside [13] - While the consensus price target may not reliably indicate the extent of SGC's gains, it does provide a useful guide for price movement direction [14]

Group 1 - Great Lakes Dredge & Dock (GLDD) closed at $11.28, with a 0.8% gain over the past four weeks, and a mean price target of $15 indicates a 33% upside potential [1] - The mean estimate includes four short-term price targets with a standard deviation of $1.41, where the lowest estimate of $14.00 suggests a 24.1% increase, and the highest estimate of $17.00 indicates a potential surge of 50.7% [2] - Analysts show strong agreement on GLDD's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock upside [4][11] Group 2 - Over the last 30 days, the Zacks Consensus Estimate for GLDD's current year has increased by 3.5%, with one estimate moving higher and no negative revisions [12] - GLDD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] - While the consensus price target may not be entirely reliable, it provides a directional guide for potential price movement [14]

Core Viewpoint - Genmab A/S Sponsored ADR (GMAB) has seen a 3.8% increase in share price over the past four weeks, closing at $22.69, with a potential upside of 33.8% based on Wall Street analysts' mean price target of $30.36 [1] Price Targets - The average price target consists of seven estimates ranging from a low of $20.00 to a high of $46.00, with a standard deviation of $8.82, indicating variability among analysts [2] - The lowest estimate suggests an 11.9% decline from the current price, while the highest estimate indicates a 102.7% upside [2] Analyst Sentiment - Analysts show a consensus that GMAB will report better earnings than previously estimated, which historically correlates with stock price increases [4][11] - The Zacks Consensus Estimate for the current year has increased by 0.1% over the past month, with one estimate rising and no negative revisions [12] Zacks Rank - GMAB holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the extent of GMAB's potential gains, it does provide a useful indication of the expected direction of price movement [14]

Core Viewpoint - Tidewater (TDW) has shown a 7.3% increase in stock price over the past four weeks, with a mean price target of $74.8 indicating a potential upside of 31.5% from the current price of $56.88 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $20.27, indicating variability among analysts; the lowest estimate is $55.00 (3.3% decline), while the highest is $108.00 (89.9% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - There is increasing optimism among analysts about TDW's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 22.8%, with one estimate moving higher and no negative revisions [12] - TDW holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a solid potential upside [13] Caution on Price Targets - While consensus price targets are often used by investors, relying solely on them may not be prudent due to historical inaccuracies in predicting stock price movements [3][7][10] - Analysts may set overly optimistic price targets influenced by business relationships, which can lead to inflated expectations [8]

Core Viewpoint - Perrigo (PRGO) shows potential for significant upside, with a mean price target of $36.67 indicating a 36% increase from the current trading price of $26.96 [1] Price Targets - The average price target consists of three estimates ranging from a low of $30.00 to a high of $42.00, with a standard deviation of $6.11, suggesting variability in analyst predictions [2] - The lowest estimate indicates an 11.3% increase, while the highest suggests a 55.8% upside [2] - A low standard deviation indicates a higher agreement among analysts regarding price movement [9] Analyst Sentiment - Analysts are increasingly optimistic about PRGO's earnings prospects, as evidenced by upward revisions in EPS estimates [11] - The Zacks Consensus Estimate for the current year has risen by 0.3% over the past month, with one estimate increasing and no negative revisions [12] - PRGO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be prudent, as analysts' ability to set accurate targets has been questioned [3][7] - Analysts often set optimistic price targets due to business incentives, which can lead to inflated estimates [8] - While price targets should not be ignored, they should be approached with skepticism and not be the sole basis for investment decisions [10]

Group 1 - Kiniksa Pharmaceuticals International, plc (KNSA) closed at $30.26, with an 8.5% gain over the past four weeks, and a mean price target of $41.14 suggests a 36% upside potential [1] - The mean estimate includes seven short-term price targets with a standard deviation of $7.45, indicating variability among analysts; the lowest estimate is $32.00 (5.8% increase), while the highest is $54.00 (78.5% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with a 26.6% increase in the Zacks Consensus Estimate for the current year, indicating potential upside for KNSA [11][12] Group 2 - KNSA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential for near-term upside [13] - The clustering of price targets with a low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement direction [9] - While price targets should not be the sole basis for investment decisions, they can provide a useful starting point for further research into the stock's fundamental drivers [10][14]